SB 217 - GENETIC PRIVACY Number 1520 CHAIR McGUIRE indicated that the next order of business would be CS FOR SENATE BILL NO. 217(JUD), "An Act relating to genetic privacy." Number 1539 SENATOR DONNY OLSON, Alaska State Legislator, sponsor, by way of presenting SB 217, surmised that everyone is familiar with how useful DNA (deoxyribonucleic acid) identification has been for law enforcement and in paternity disputes. He remarked, though, that he is very concerned about genetic privacy because, currently, state laws restrict access to medical records but not to genetic information; SB 217 seeks to curtail exploitation of valuable genetic information. Although there are no federal statutes regarding genetic privacy, 15 states require informed consent before a third party performs or requires a genetic test or obtains genetic information, and 23 states require informed consent before disclosing genetic information. In conclusion, he said that SB 217 gives consideration to advancing biotechnology in DNA analysis while also giving Alaskans the right to keep their genetic information private. REPRESENTATIVE SAMUELS asked Senator Olson whether there were any possible exceptions that he considered but did not include in the bill. SENATOR OLSON indicated that there weren't, and highlighted the exceptions currently listed in the bill. He noted that SB 217 requires informed consent before someone can collect, distribute, or use a person's genetic information. REPRESENTATIVE OGG asked whether SB 217 prevents the use of samples collected from public places such as bathrooms. SENATOR OLSON reiterated that under the bill, unless one of the listed exceptions applies, informed consent is required before someone can collect, distribute, or use a person's genetic information. Number 1862 REPRESENTATIVE GARA asked under what circumstances, currently, might someone unknowingly have his/her DNA taken. SENATOR OLSON ventured that such might occur when a person gives a blood sample or a semen sample. REPRESENTATIVE GARA said he would not want someone to go to a private medical clinic, for example, sign several large, complex release forms without knowing that one of the forms includes an informed consent release pertaining to the use of genetic information. He suggested that perhaps future consideration might be given to requiring that an informed consent release regarding genetic information be provided for in a separate document. SENATOR OLSON said he has given that issue consideration, and noted that page 2, line 14, states: "A person may revoke or amend their informed and written consent at any time". The committee took an at-ease from 7:20 p.m. to 7:21 p.m. REPRESENTATIVE OGG complimented Senator Olson on a well-crafted bill. REPRESENTATIVE GARA concurred. CHAIR McGUIRE indicated that SB 217 would be held over for the purpose of considering a proposed amendment submitted by the insurance industry.